Abstract 1602P
Background
When a child has a life-limiting, irreversible condition such as advanced cancer, a healthcare team and family may decide to limit care lacking clear benefit. In such circumstances, a compassionate extubation, or discontinuation of life-sustaining ventilator support allowing natural death, may be pursued. Compassionate extubations are an infrequently performed procedure with complexities that include difficult conversations and dynamic symptom management which can lend to this being a challenging process to execute, particularly without opportunity for practice. Simulation can be a helpful tool to enhance knowledge, confidence, and preparedness with unfamiliar or uncommon scenarios in a safe environment. A compassionate extubation simulation training experience focusing on the conversational and technical skills was implemented within the Pediatric Intensive Care Unit at an academic medical center in New York City. The aim of the project was to determine whether participation in one simulation training improved healthcare providers’ confidence with performing a compassionate extubation.
Methods
A one group pretest-posttest design project was implemented using The Confidence Scale to evaluate RN and APRN confidence with performing a compassionate extubation before and after the simulation. The sample was described using descriptive statistical analysis and the Wilcoxon signed-rank test was used to evaluate for differences between first and second observations.
Results
A Wilcoxon signed-rank test determined that the compassionate extubation simulation elicited a statistically significant median increase in C-Scale scores after participation in the simulation (median = 20) compared to C-Scale scores prior (median = 12), W = 45, p = 0.007.
Conclusions
Affording opportunity for healthcare providers to sculpt and refine their practice with certain challenging clinical scenarios has been shown to improve their confidence navigating these situations. All efforts to improve confidence related to sensitive situations such as with a compassionate extubation are made with the intention of improving the experience of children at the end of their lives as well as the experiences of the families and loved ones who walk this journey with them.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The author.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1999P - IMreal Cohort 4: Third interim analysis of efficacy and safety in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC) receiving atezolizumab plus carboplatin and etoposide (atezo + CE) as first-line (1L) therapy under real-world conditions (RWCs)
Presenter: Sanjay Popat
Session: Poster session 05
2000P - Efficacy and safety of thoracic radiotherapy after first-line immunotherapy in extensive stage small cell lung cancer: A multi-center retrospective study
Presenter: Jiake Wu
Session: Poster session 05
2001P - Consolidative thoracic radiotherapy of extensive-stage small cell lung cancer in the era of chemoimmunotherapy: A retrospective analysis concerning patients from southern Italy
Presenter: Vito Longo
Session: Poster session 05
2002P - A multicentre study assessing the real-world effectiveness of first-line chemotherapy plus immunotherapy in extensive-stage small cell lung cancer (ES-SCLC) patients
Presenter: Marie Porte
Session: Poster session 05
2003P - Consolidative intrathoracic radiotherapy during maintenance first-line immunotherapy in extensive stage small cell lung cancer (ES-SCLC): A retrospective multicenter analysis of safety and efficacy
Presenter: Alessio Bruni
Session: Poster session 05
2004P - PD-L1 Inhibitors combined with whole brain radiotherapy in patients with small cell lung cancer brain metastases: Real-world evidence
Presenter: Litang Huang
Session: Poster session 05
2005P - Anlotinib combined with chemotherapy in the treatment of first-line extensive-stage small cell lung cancer (ES-SCLC): A real-world study
Presenter: Fangfang Gao
Session: Poster session 05
2006P - Immune activation effect and survival of different irradiated sites in ES-SCLC patients treated with radioimmunotherapy: A real-world analysis
Presenter: Min Wu
Session: Poster session 05
2007P - Real-world (rw) outcomes to chemoimmunotherapy and biomarker analysis in extensive-stage small cell lung cancer (ES SCLC)
Presenter: Emmanouil Panagiotou
Session: Poster session 05